Search - tctmd.com

Displaying 961 - 980 of 2866

Sort: Relevancy | Date

Presentation TCT 2019

Presentation of Case Study

Presenter: Andrew Klein

September 26, 2019

Presentation TCT 2019

Portugal Presents: Percutaneous Treatment of Aortic Dissection and Rupture During a Transcatheter Aortic Valve Implantation Procedure

Presenter: Pedro de Araujo Goncalves

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Presenter: Ian Meredith AM

September 26, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Presentation TCT 2019

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Presenter: Jay Giri

September 26, 2019

Presentation TCT 2019

Case #4: OCT-Guided Laser Therapy in ISR

Presenter: Peter O'Kane

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients in Japan

Presenter: Yasuko Nakamura

September 26, 2019

Featured Technological Trends - How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Presentation TCT 2019

How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Presenter: James Heywood

September 26, 2019

Presentation TCT 2019

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Presenter: Elazer Edelman

September 26, 2019

Presentation TCT 2019

Is There a Role for Coronary Physiology in Patients Referred for CABG?

Presenter: Petr Kala

September 26, 2019

Presentation TCT 2019

Case #3: Same Strategy With or Without OCT in ISR?

Presenter: Colm Hanratty

September 26, 2019

Featured Technological Trends - A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

Presentation TCT 2019

A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

Presenter: William Abraham

September 26, 2019

Presentation TCT 2019

No Reflow: How to Prevent It and How to Fix It!

Presenter: Mitul Patel

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Presenter: Adrian Magee

September 26, 2019

Presentation TCT 2019

PERT: Why and How

Presenter: Robert Lookstein

September 26, 2019

Presentation TCT 2019

Conduction Disturbances After TAVR: Current Thinking and Clinical Relevance

Presenter: Tamim Nazif

September 26, 2019

Presentation TCT 2019

Argentina Presents: Is TAVR an Option for Patients With Bicuspid Aortic Stenosis and Aortic Root Dilatation?

Presenter: Anibal Damonte

September 26, 2019

Presentation TCT 2019

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Presenter: Krishna Rocha-Singh

September 26, 2019

Presentation TCT 2019

Pre-TAVR Coronary Physiology in Patients With Severe Aortic Stenosis: Are the Results Valid?

Presenter: Sukhjinder Nijjer

September 26, 2019

Advertisement

Presentation of Case Study

Portugal Presents: Percutaneous Treatment of Aortic Dissection and Rupture During a Transcatheter Aortic Valve Implantation Procedure

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Drug-Eluting Technologies for SFA Disease: Industry’s Perspective and a Pathway Forward

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Systemic Therapy for Acute PE: Options, Effectiveness, Safety

Case #4: OCT-Guided Laser Therapy in ISR

Study Design Considerations for HBR Patients in Japan

How the Use of Noninvasive Cardiac Output Measurement Can (Could) Help You Manage Your Heart Failure Patient (Vital Metrix)

Is Paclitaxel-Related Mortality From SFA Drug-Eluting Technologies Biologically Plausible?

Is There a Role for Coronary Physiology in Patients Referred for CABG?

Case #3: Same Strategy With or Without OCT in ISR?

A First-in-Human, Multicenter Open-Label Prospective Study to Evaluate the Safety, Usability, and Performance of the V-Lap System

No Reflow: How to Prevent It and How to Fix It!

Study Design Considerations for HBR Patients and DES Platforms: FDA View

PERT: Why and How

Conduction Disturbances After TAVR: Current Thinking and Clinical Relevance

Argentina Presents: Is TAVR an Option for Patients With Bicuspid Aortic Stenosis and Aortic Root Dilatation?

Paclitaxel-Coated Devices for SFA Disease: An Independent, Patient-Level Meta-Analysis and Other Emerging Data

Pre-TAVR Coronary Physiology in Patients With Severe Aortic Stenosis: Are the Results Valid?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content